The Role of Cytokines in the Changes in Bone Turnover Following Bone Marrow Transplantation

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Osteoporosis International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s198-002-8339-5PMID 11878457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The short-term changes of bone mineral metabolism following bone marrow transplantation.

  2000cited by this paper
• Mechanisms of Bone Loss Following Allogeneic and Autologous Hemopoietic Stem Cell Transplantation

  1999influential reference
• IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.

  1998cited by this paper
• Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation.

  1997cited by this paper
• Reduction of Bone Mass in Women after Bone Marrow Transplantation

  1997cited by this paper
• Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.

  1996cited by this paper
• Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.

  1996cited by this paper
• Relationship between Bone Metabolism and Plasma Cytokine Levels in Patients at Risk of Post-Transplantation Bone Disease after Bone Marrow Transplantation

  1996cited by this paper
• Interleukin-6 (IL-6) levels in febrile children during maximal aplasia after bone marrow transplantation (BMT) are similar to those in children with normal hematopoiesis

  1995cited by this paper
• Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

  1995cited by this paper
• Bone marrow, cytokines, and bone remodeling

  1995cited by this paper
• Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism

  1994cited by this paper
• Osteoporosis and bone morbidity in cardiac transplant recipients.

  1994cited by this paper
• Stromal Cell-Mediated Stimulation of Osteoclastogenesis

  1994cited by this paper
• Interleukin-6 and soluble interleukin-6 receptor in synovial fluid of patients with rheumatoid arthritis

  1994cited by this paper
• Bone disease after liver transplantation.

  1992cited by this paper
• Increased osteoclast development after estrogen loss: mediation by interleukin-6.

  1992cited by this paper
• Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

  1992cited by this paper
• Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia.

  1991cited by this paper
• Rapid loss of vertebral mineral density after renal transplantation.

  1991cited by this paper
• Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.

  1989cited by this paper
• BONE HISTOLOGY IN RENAL TRANSPLANT PATIENTS RECEIVING CYCLOSPORIN

  1988cited by this paper
• Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors

  1986cited by this paper

• Osteoporosis in organ transplant patients

  2021cites this paper
• Risk factors for haematopoietic stem cell transplant (HSCT) associated bone loss: bone marrow transplantation associated bone loss.

  2020cites this paper
• Transplantation Osteoporosis

  2020cites this paper
• Guidance to bone morbidity in children and adolescents undergoing allogeneic hematopoietic stem cell transplantation.

  2020cites this paper
• Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients

  2020cites this paper
• Évolution de la densité minérale osseuse chez les patients avec une hémopathie traitée par allogreffe de cellules souches hématopoïétiques

  2019cites this paper
• Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy

  2018cites this paper
• Changes in Bone Health During the First Year of Cancer Treatment in Children.

  2017cites this paper
• Bone and the Immune System

  2017cites this paper
• Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion

  2017cites this paper
• Characterization of Fatty Acid Composition in Bone Marrow Fluid From Postmenopausal Women: Modification After Hip Fracture

  2016cites this paper
• Qualitative Aspects of Bone Marrow Adiposity in Osteoporosis

  2016cites this paper
• Osteoporosis in Organ Transplant Patients

  2016cites this paper
• Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation

  2015cites this paper
• Improvement of Hematopoietic and Immunologic Findings in Sublethal Gamma Irradiated Rats Treated with Bone Marrow Transplantation and Wheat Germ Oil

  2015cites this paper
• Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries.

  2014cites this paper
• The role of insulin-like growth factor 1, receptor activator for nuclear factor κB ligand - osteoprotegerin system, interleukin 6 and 1β in post-transplantation bone metabolic disease in childhood.

  2013cites this paper
• Factors Related to Decreased Bone Mineral Density in Childhood Cancer Survivors

  2013cites this paper
• Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.

  2012cites this paper
• In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis.

  2012cites this paper
• Post-transplantation osteoporosis.

  2010cites this paper
• Post-transplantation osteoporosis Osteoporose pós-transplante

  2010cites this paper
• Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women

  2010cites this paper
• Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects

  2009cites this paper
• Genetics, cellular biology and tumor microenvironment of melanoma.

  2009cites this paper
• Biomarkers of bone and mineral metabolism following bone marrow transplantation.

  2009cites this paper
• Chapter 5 Biomarkers of bone and mineral metabolism following bone marrow transplantation

  2009cites this paper
• Osteoporosis Associated with Cancer Therapy

  2008cites this paper
• Post-transplantation osteoporosis.

  2007cites this paper
• Endocrine complications of hematopoietic stem cell transplantation.

  2007cites this paper
• Bone loss and its management in long-term survivors from allogeneic stem cell transplantation.

  2007cites this paper
• Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation

  2007cites this paper
• REVIEW: Bone Loss and Its Management in Long-Term Survivors from Allogeneic Stem Cell Transplantation

  2007cites this paper
• Review Senile osteoporosis: Is it an immune-mediated disease?

  2006cites this paper
• Pamidronate reduces bone loss after allogeneic stem cell transplantation.

  2006cites this paper
• Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.

  2006cites this paper
• Senile osteoporosis: Is it an immune-mediated disease?

  2006cites this paper
• Osteoporose pós-transplante

  2006cites this paper
• Meeting report from skeletal complications of malignancy IV

  2006cites this paper
• Ethical Considerations in Pediatric Hematopoietic Stem-Cell Transplantation

  2006cites this paper
• Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

  2005cites this paper
• The Changes in the Serum RANKL and OPG levels after Bone Marrow Transplantation: Association with Bone Mineral Metabolism

  2005cites this paper
• Endocrine late effects of cancer treatment.

  2005cites this paper
• CHAPTER 6 – Bone and the Immune System

  2005cites this paper
• Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.

  2005cites this paper
• Bone mass and turnover after allogeneic stem cell transplantation

  2005cites this paper
• Bone disease after bone marrow transplantation

  2005cites this paper
• Maldaptation of the link between inflammation and bone turnover may be a key determinant of osteoporosis.

  2004cites this paper
• Hemostatic Abnormalities and Changes Following Bone Marrow Transplantation

  2004cites this paper
• Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.

  2004cites this paper
• Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation

  2004cites this paper
• Relationship Between Low Bone Mineral Density and Highly Active Antiretroviral Therapy Including Protease Inhibitors in HIV-Infected Patients

  2003cites this paper
• Endocrine late effects of cancer treatment

  2003cites this paper
• Marrow Cell Transplantation for Infantile Hypophosphatasia

  2003cites this paper
• Osteoporosis: Pathophysiology and Clinical Management

  2003cites this paper
• The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study.

  2002cites this paper
• Meeting report from the IOF world congress on osteoporosis

  2002cites this paper
• Transplantation osteoporosis

  2001cites this paper